Vertex gets US regulator’s nod for extended use of cystic fibrosis drug
Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six.
Uncategorized
Eli Lilly to expand US facility as demand soars for diabetes, obesity medicines
Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for.
Drugs
Medical
Pharma
AstraZeneca, Daiichi’s trial drug for lung cancer, gets US regulator’s nod
The US regulator has granted a breakthrough therapy designation to British-Swedish AstraZeneca and Japan’s Daiichi Sankyo experimental drug for treating a certain type.
Drugs
Medical
Pharma
AstraZeneca’s drug gets nod to treat limited-stage cell lung cancer patients
The US regulator has approved AstraZeneca’s blockbuster drug Imfinzi to treat adults with limited-stage cell lung cancer.
Drugs
Health
Medical
California state confirms two cases of bird flu, US total stands at 16 now
The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year.
Drugs
Health
Pharma
Amgen’s trial drug to fight autoimmune disorder improves patient outcomes
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial.
Drugs
Health
Pharma
FDA faces Vanda’s ire as it rejects firm’s gastroparesis drug application
Vanda Pharmaceuticals Inc’s gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for.